Thursday Feb 9 | Bloomberg
Watson CEO Seeks Deal in Brand-Name Drugs
Watson Pharmaceuticals Inc. Chief Executive Officer Paul Bisaro is looking to acquire brand-name drug assets and make a future "'transformational'' purchase as he reshapes the generic-drug maker.
Renown Health recognized by IMS Health Inc.
Renown Health was recognized as a Top 100 Integrated Health Network for the ninth year in a row by IMS Health Inc.
WuXi's Margins Dwarfing U.S. Lead China's Drug Targets: Real M&A
Companies looking to profit from the world's fastest growing drug market and conduct animal research at half the cost of U.S. testing are making China's WuXi PharmaTech Inc.
FTC Seeks Public Comment on Healthcare Technology's Application to...
A divestiture is required by the final FTC settlement order allowing Healthcare Technology's subsidiary IMS Health Inc.
IMS Acquires PharmARC in India, Strengthening Global Services Capabilities
IMS Health has acquired PharmARC, an India-based company specializing in commercial analytics and services for the life sciences industry.
inVentiv Health to Acquire SDI Promotional and Medical Audit Businesses From IMS Health
BURLINGTON, Mass., Jan. 17, 2012 /PRNewswire/ -- inVentiv Health, Inc., offering best-in-class clinical, commercial and consulting services to the healthcare industry, today announced that it has entered into a definitive agreement to acquire certain promotional and medical audit businesses of SDI Health, which IMS Health has committed to divest in ... (more)
Also on Topix